Agios Pharmaceuticals Inc (AGIO)
44.66
-0.21
(-0.47%)
USD |
NASDAQ |
Nov 04, 13:08
Agios Pharmaceuticals Price to Book Value: 3.847 for Nov. 4, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 01, 2024 | 3.865 |
| October 31, 2024 | 3.827 |
| October 30, 2024 | 3.988 |
| October 29, 2024 | 4.034 |
| October 28, 2024 | 3.969 |
| October 25, 2024 | 3.884 |
| October 24, 2024 | 3.883 |
| October 23, 2024 | 3.818 |
| October 22, 2024 | 3.909 |
| October 21, 2024 | 3.933 |
| October 18, 2024 | 3.919 |
| October 17, 2024 | 3.802 |
| October 16, 2024 | 3.764 |
| October 15, 2024 | 3.621 |
| October 14, 2024 | 3.556 |
| October 11, 2024 | 3.674 |
| October 10, 2024 | 3.602 |
| October 09, 2024 | 3.522 |
| October 08, 2024 | 3.488 |
| October 07, 2024 | 3.496 |
| October 04, 2024 | 3.560 |
| October 03, 2024 | 3.494 |
| October 02, 2024 | 3.600 |
| October 01, 2024 | 3.658 |
| September 30, 2024 | 3.827 |
| Date | Value |
|---|---|
| September 27, 2024 | 3.929 |
| September 26, 2024 | 4.139 |
| September 25, 2024 | 4.223 |
| September 24, 2024 | 4.013 |
| September 23, 2024 | 3.942 |
| September 20, 2024 | 4.010 |
| September 19, 2024 | 4.081 |
| September 18, 2024 | 3.923 |
| September 17, 2024 | 3.936 |
| September 16, 2024 | 3.911 |
| September 13, 2024 | 4.022 |
| September 12, 2024 | 3.869 |
| September 11, 2024 | 3.817 |
| September 10, 2024 | 3.835 |
| September 09, 2024 | 3.784 |
| September 06, 2024 | 3.728 |
| September 05, 2024 | 3.793 |
| September 04, 2024 | 3.854 |
| September 03, 2024 | 3.853 |
| August 30, 2024 | 3.954 |
| August 29, 2024 | 3.950 |
| August 28, 2024 | 3.907 |
| August 27, 2024 | 4.056 |
| August 26, 2024 | 4.011 |
| August 23, 2024 | 3.981 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.7741
Minimum
Jun 14 2022
9.983
Maximum
Feb 11 2021
2.945
Average
1.616
Median
Jul 13 2023
Price to Book Value Benchmarks
| Pfizer Inc | 1.799 |
| Regeneron Pharmaceuticals Inc | 3.141 |
| Ligand Pharmaceuticals Inc | 2.587 |
| ADMA Biologics Inc | 23.84 |
| AnaptysBio Inc | 55.85 |
Price to Book Value Related Metrics
| PS Ratio | 80.21 |
| PEG Ratio | -0.0967 |
| Price | 44.66 |
| Earnings Yield | -14.55% |
| Market Cap | 2.541B |
| PEGY Ratio | -0.0967 |